NCT03787199

Brief Summary

The overall aim of this project is to investigate the clinical utility of the Andago System, a CE certified mobile bodyweight supporting walking robot, in children with neuromotor disorders. Clinical utility encompasses practicability, acceptability, appropriateness, and accessibility. In this study, the investigators would like to investigate several aspects of clinical utility that belong to the first three components.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

May 28, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2019

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2019

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

10 months

First QC Date

April 23, 2018

Last Update Submit

April 17, 2019

Conditions

Keywords

AndagoFeasibilityPediatric Neurorehabilitation

Outcome Measures

Primary Outcomes (1)

  • Stride to stride variability

    Variability in stride length recorded during at least 20 steps for each of the following conditions: Andago with reference bodyweight support; Andago with 15% more bodyweight support; Andago with 30% more bodyweight support; and treadmill condition with reference bodyweight support

    Appointment 3 (between minute 25 and minute 55 )

Secondary Outcomes (2)

  • Leg muscle activity

    Appointment 3 (between minute 25 and minute 55 )

  • Leg joint angles

    Appointment 3 (between minute 25 and minute 55)

Other Outcomes (9)

  • Bodyweight unloading [kg]

    Data are obtained during Appointment 2 (between minute 1 and minute 10)

  • Number of device stops

    Data are obtained during Appointment 1 between minute 25 and minute 45 and Appointment 2 between minute 10 to 30

  • Customized questionnaire investigating acceptability [dichotomous]

    At the end of Appointments 1 (between minute 55-58) and the end of Appointment 2 (between minute 40-43)

  • +6 more other outcomes

Study Arms (2)

Andago

EXPERIMENTAL

Application of walking over-ground with body-weight support in the Andago

Device: Andago

Treadmill

ACTIVE COMPARATOR

Application of walking on a treadmill with body-weight support

Other: Treadmill

Interventions

AndagoDEVICE

The Andago is a body-weight supporting device with which a patient can walk overground

Andago

Bodyweight supported treadmill walking

Treadmill

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Neuromotor or orthopaedic disorders
  • taller than 135 cm
  • able to understand simple instructions
  • able to walk 10 meters with or without walking aid
  • maximal age of 18 years (a minimal age is not defined as according to the growth curve, children younger than 7-8 years cannot be included because of insufficient height)
  • given informed consent.

You may not qualify if:

  • not consolidated fractures or bone fragility of the lower extremities
  • skin lesions in the harness' area which cannot be protected
  • unstable hip, knee and/or ankle Joints
  • reduced head control or inability to maintain an upright Position
  • inability to communicate discomfort or pain
  • surgery in the last 3 months
  • newly implanted baclofen-pump (or children highly sensitive to it)
  • implanted pacemakers
  • passive knee extension deficit \> 30°
  • self-selected walking speed \> 3.2 km/h.
  • weight \> 135 kg
  • height \> 2 m.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Center of the University Children's Hospital

Affoltern am Albis, Canton of Zurich, 8910, Switzerland

Location

Related Publications (1)

  • van Hedel HJA, Rosselli I, Baumgartner-Ricklin S. Clinical utility of the over-ground bodyweight-supporting walking system Andago in children and youths with gait impairments. J Neuroeng Rehabil. 2021 Feb 8;18(1):29. doi: 10.1186/s12984-021-00827-1.

MeSH Terms

Conditions

Gait Disorders, NeurologicCerebral PalsyStrokeBrain Injuries, Traumatic

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Feasibility study, including a comparison between Andago and treadmill walking conditions (as we include a heterogeneous group of participants concerning age (children/adolescents), diagnosis, walking ability, etc., we include in this feasibility study 20 participants - rather than the usual 10). Patients participate in 3 appointments (planned within 10 days): Appointment 1 (60 min): patient characteristics, clinical tests (Selective Control Assessment of the Lower Extremity / Manual Muscle Testing / 10 meter walk test or 10MWT); practising on treadmill and in Andago; questions to participants Appointment 2 (45 min): determine accuracy of the unloading system; practicing on treadmill and in Andago; questions to participant Appointment 3 (60-90 min): 10MWT at onset and end; measurement of stride length, leg muscle EMG and joint kinematics during walking on treadmill with bodyweight unloading and walking overground with Andago with 3 levels of bodyweight unloading
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2018

First Posted

December 26, 2018

Study Start

May 28, 2018

Primary Completion

March 19, 2019

Study Completion

March 21, 2019

Last Updated

April 18, 2019

Record last verified: 2019-04

Locations